▶ 調査レポート

小児脳腫瘍の世界市場(~2026年)

• 英文タイトル:Global Pediatric Brain Tumor Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。小児脳腫瘍の世界市場(~2026年) / Global Pediatric Brain Tumor Market Size, Status and Forecast 2020-2026 / MRC2-11QY04192資料のイメージです。• レポートコード:MRC2-11QY04192
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は小児脳腫瘍のグローバル市場について調査・分析したレポートです。種類別(神経膠腫、混合神経膠腫、胚性腫瘍、脈絡叢乳頭腫/癌、非神経上皮組織発生腫瘍、髄膜腫瘍)市場規模、用途別(病院および診療所、医学研究センター、学術研究所)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別小児脳腫瘍の競争状況、市場シェア
・世界の小児脳腫瘍市場:種類別市場規模 2015年-2020年(神経膠腫、混合神経膠腫、胚性腫瘍、脈絡叢乳頭腫/癌、非神経上皮組織発生腫瘍、髄膜腫瘍)
・世界の小児脳腫瘍市場:種類別市場規模予測 2021年-2026年(神経膠腫、混合神経膠腫、胚性腫瘍、脈絡叢乳頭腫/癌、非神経上皮組織発生腫瘍、髄膜腫瘍)
・世界の小児脳腫瘍市場:用途別市場規模 2015年-2020年(病院および診療所、医学研究センター、学術研究所)
・世界の小児脳腫瘍市場:用途別市場規模予測 2021年-2026年(病院および診療所、医学研究センター、学術研究所)
・北米の小児脳腫瘍市場分析:米国、カナダ
・ヨーロッパの小児脳腫瘍市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの小児脳腫瘍市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の小児脳腫瘍市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの小児脳腫瘍市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Abbott、AbbVie、Akorn、Agios、Baxter、Bayer、Epizyme、Novartis、Mylan
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Pediatric brain tumors are masses or growths of abnormal cells that occur in a child’s brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant).
Treatment and chance of recovery (prognosis) depend on the type of tumor, its location within the brain, whether it has spread, and your child’s age and general health. Because new treatments and technologies are continually being developed, several options may be available at different points in treatment.

Market Analysis and Insights: Global Pediatric Brain Tumor Market
The global Pediatric Brain Tumor market size is projected to reach US$ 1302.6 million by 2026, from US$ 1270.7 million in 2020, at a CAGR of 2.3%% during 2021-2026.

Global Pediatric Brain Tumor Scope and Market Size
Pediatric Brain Tumor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Brain Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott
AbbVie
Akorn
Agios
Baxter
Bayer
Epizyme
Novartis
Mylan

Market segment by Type, the product can be split into
Gliomas
Mixed Neuronal-Glial Tumors
Embryonal Tumors
Choroid Plexus Papilloma/Carcinoma
Tumors Arising From Non-Neuroepithelial Tissue
Meningeal Tumors
Market segment by Application, split into
Hospitals And Clinics
Medical Research Centers
Academic Institutes

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pediatric Brain Tumor Revenue
1.4 Market by Type
1.4.1 Global Pediatric Brain Tumor Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Gliomas
1.4.3 Mixed Neuronal-Glial Tumors
1.4.4 Embryonal Tumors
1.4.5 Choroid Plexus Papilloma/Carcinoma
1.4.6 Tumors Arising From Non-Neuroepithelial Tissue
1.4.7 Meningeal Tumors
1.5 Market by Application
1.5.1 Global Pediatric Brain Tumor Market Share by Application: 2020 VS 2026
1.5.2 Hospitals And Clinics
1.5.3 Medical Research Centers
1.5.4 Academic Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Pediatric Brain Tumor Market Perspective (2015-2026)
2.2 Global Pediatric Brain Tumor Growth Trends by Regions
2.2.1 Pediatric Brain Tumor Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pediatric Brain Tumor Historic Market Share by Regions (2015-2020)
2.2.3 Pediatric Brain Tumor Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pediatric Brain Tumor Market Growth Strategy
2.3.6 Primary Interviews with Key Pediatric Brain Tumor Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pediatric Brain Tumor Players by Market Size
3.1.1 Global Top Pediatric Brain Tumor Players by Revenue (2015-2020)
3.1.2 Global Pediatric Brain Tumor Revenue Market Share by Players (2015-2020)
3.1.3 Global Pediatric Brain Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pediatric Brain Tumor Market Concentration Ratio
3.2.1 Global Pediatric Brain Tumor Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pediatric Brain Tumor Revenue in 2019
3.3 Pediatric Brain Tumor Key Players Head office and Area Served
3.4 Key Players Pediatric Brain Tumor Product Solution and Service
3.5 Date of Enter into Pediatric Brain Tumor Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Pediatric Brain Tumor Historic Market Size by Type (2015-2020)
4.2 Global Pediatric Brain Tumor Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Pediatric Brain Tumor Market Size by Application (2015-2020)
5.2 Global Pediatric Brain Tumor Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pediatric Brain Tumor Market Size (2015-2020)
6.2 Pediatric Brain Tumor Key Players in North America (2019-2020)
6.3 North America Pediatric Brain Tumor Market Size by Type (2015-2020)
6.4 North America Pediatric Brain Tumor Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pediatric Brain Tumor Market Size (2015-2020)
7.2 Pediatric Brain Tumor Key Players in Europe (2019-2020)
7.3 Europe Pediatric Brain Tumor Market Size by Type (2015-2020)
7.4 Europe Pediatric Brain Tumor Market Size by Application (2015-2020)

8 China
8.1 China Pediatric Brain Tumor Market Size (2015-2020)
8.2 Pediatric Brain Tumor Key Players in China (2019-2020)
8.3 China Pediatric Brain Tumor Market Size by Type (2015-2020)
8.4 China Pediatric Brain Tumor Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pediatric Brain Tumor Market Size (2015-2020)
9.2 Pediatric Brain Tumor Key Players in Japan (2019-2020)
9.3 Japan Pediatric Brain Tumor Market Size by Type (2015-2020)
9.4 Japan Pediatric Brain Tumor Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pediatric Brain Tumor Market Size (2015-2020)
10.2 Pediatric Brain Tumor Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pediatric Brain Tumor Market Size by Type (2015-2020)
10.4 Southeast Asia Pediatric Brain Tumor Market Size by Application (2015-2020)

11 India
11.1 India Pediatric Brain Tumor Market Size (2015-2020)
11.2 Pediatric Brain Tumor Key Players in India (2019-2020)
11.3 India Pediatric Brain Tumor Market Size by Type (2015-2020)
11.4 India Pediatric Brain Tumor Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pediatric Brain Tumor Market Size (2015-2020)
12.2 Pediatric Brain Tumor Key Players in Central & South America (2019-2020)
12.3 Central & South America Pediatric Brain Tumor Market Size by Type (2015-2020)
12.4 Central & South America Pediatric Brain Tumor Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Pediatric Brain Tumor Introduction
13.1.4 Abbott Revenue in Pediatric Brain Tumor Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 AbbVie
13.2.1 AbbVie Company Details
13.2.2 AbbVie Business Overview
13.2.3 AbbVie Pediatric Brain Tumor Introduction
13.2.4 AbbVie Revenue in Pediatric Brain Tumor Business (2015-2020)
13.2.5 AbbVie Recent Development
13.3 Akorn
13.3.1 Akorn Company Details
13.3.2 Akorn Business Overview
13.3.3 Akorn Pediatric Brain Tumor Introduction
13.3.4 Akorn Revenue in Pediatric Brain Tumor Business (2015-2020)
13.3.5 Akorn Recent Development
13.4 Agios
13.4.1 Agios Company Details
13.4.2 Agios Business Overview
13.4.3 Agios Pediatric Brain Tumor Introduction
13.4.4 Agios Revenue in Pediatric Brain Tumor Business (2015-2020)
13.4.5 Agios Recent Development
13.5 Baxter
13.5.1 Baxter Company Details
13.5.2 Baxter Business Overview
13.5.3 Baxter Pediatric Brain Tumor Introduction
13.5.4 Baxter Revenue in Pediatric Brain Tumor Business (2015-2020)
13.5.5 Baxter Recent Development
13.6 Bayer
13.6.1 Bayer Company Details
13.6.2 Bayer Business Overview
13.6.3 Bayer Pediatric Brain Tumor Introduction
13.6.4 Bayer Revenue in Pediatric Brain Tumor Business (2015-2020)
13.6.5 Bayer Recent Development
13.7 Epizyme
13.7.1 Epizyme Company Details
13.7.2 Epizyme Business Overview
13.7.3 Epizyme Pediatric Brain Tumor Introduction
13.7.4 Epizyme Revenue in Pediatric Brain Tumor Business (2015-2020)
13.7.5 Epizyme Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Pediatric Brain Tumor Introduction
13.8.4 Novartis Revenue in Pediatric Brain Tumor Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Mylan
13.9.1 Mylan Company Details
13.9.2 Mylan Business Overview
13.9.3 Mylan Pediatric Brain Tumor Introduction
13.9.4 Mylan Revenue in Pediatric Brain Tumor Business (2015-2020)
13.9.5 Mylan Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Pediatric Brain Tumor Key Market Segments
Table 2. Key Players Covered: Ranking by Pediatric Brain Tumor Revenue
Table 3. Ranking of Global Top Pediatric Brain Tumor Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pediatric Brain Tumor Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gliomas
Table 6. Key Players of Mixed Neuronal-Glial Tumors
Table 7. Key Players of Embryonal Tumors
Table 8. Key Players of Choroid Plexus Papilloma/Carcinoma
Table 9. Key Players of Tumors Arising From Non-Neuroepithelial Tissue
Table 10. Key Players of Meningeal Tumors
Table 11. Global Pediatric Brain Tumor Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Pediatric Brain Tumor Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Pediatric Brain Tumor Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Pediatric Brain Tumor Market Share by Regions (2015-2020)
Table 15. Global Pediatric Brain Tumor Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Pediatric Brain Tumor Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Pediatric Brain Tumor Market Growth Strategy
Table 21. Main Points Interviewed from Key Pediatric Brain Tumor Players
Table 22. Global Pediatric Brain Tumor Revenue by Players (2015-2020) (Million US$)
Table 23. Global Pediatric Brain Tumor Market Share by Players (2015-2020)
Table 24. Global Top Pediatric Brain Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Brain Tumor as of 2019)
Table 25. Global Pediatric Brain Tumor by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Pediatric Brain Tumor Product Solution and Service
Table 28. Date of Enter into Pediatric Brain Tumor Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Pediatric Brain Tumor Market Size by Type (2015-2020) (Million US$)
Table 31. Global Pediatric Brain Tumor Market Size Share by Type (2015-2020)
Table 32. Global Pediatric Brain Tumor Revenue Market Share by Type (2021-2026)
Table 33. Global Pediatric Brain Tumor Market Size Share by Application (2015-2020)
Table 34. Global Pediatric Brain Tumor Market Size by Application (2015-2020) (Million US$)
Table 35. Global Pediatric Brain Tumor Market Size Share by Application (2021-2026)
Table 36. North America Key Players Pediatric Brain Tumor Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Pediatric Brain Tumor Market Share (2019-2020)
Table 38. North America Pediatric Brain Tumor Market Size by Type (2015-2020) (Million US$)
Table 39. North America Pediatric Brain Tumor Market Share by Type (2015-2020)
Table 40. North America Pediatric Brain Tumor Market Size by Application (2015-2020) (Million US$)
Table 41. North America Pediatric Brain Tumor Market Share by Application (2015-2020)
Table 42. Europe Key Players Pediatric Brain Tumor Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Pediatric Brain Tumor Market Share (2019-2020)
Table 44. Europe Pediatric Brain Tumor Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Pediatric Brain Tumor Market Share by Type (2015-2020)
Table 46. Europe Pediatric Brain Tumor Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Pediatric Brain Tumor Market Share by Application (2015-2020)
Table 48. China Key Players Pediatric Brain Tumor Revenue (2019-2020) (Million US$)
Table 49. China Key Players Pediatric Brain Tumor Market Share (2019-2020)
Table 50. China Pediatric Brain Tumor Market Size by Type (2015-2020) (Million US$)
Table 51. China Pediatric Brain Tumor Market Share by Type (2015-2020)
Table 52. China Pediatric Brain Tumor Market Size by Application (2015-2020) (Million US$)
Table 53. China Pediatric Brain Tumor Market Share by Application (2015-2020)
Table 54. Japan Key Players Pediatric Brain Tumor Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Pediatric Brain Tumor Market Share (2019-2020)
Table 56. Japan Pediatric Brain Tumor Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Pediatric Brain Tumor Market Share by Type (2015-2020)
Table 58. Japan Pediatric Brain Tumor Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Pediatric Brain Tumor Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Pediatric Brain Tumor Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Pediatric Brain Tumor Market Share (2019-2020)
Table 62. Southeast Asia Pediatric Brain Tumor Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Pediatric Brain Tumor Market Share by Type (2015-2020)
Table 64. Southeast Asia Pediatric Brain Tumor Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Pediatric Brain Tumor Market Share by Application (2015-2020)
Table 66. India Key Players Pediatric Brain Tumor Revenue (2019-2020) (Million US$)
Table 67. India Key Players Pediatric Brain Tumor Market Share (2019-2020)
Table 68. India Pediatric Brain Tumor Market Size by Type (2015-2020) (Million US$)
Table 69. India Pediatric Brain Tumor Market Share by Type (2015-2020)
Table 70. India Pediatric Brain Tumor Market Size by Application (2015-2020) (Million US$)
Table 71. India Pediatric Brain Tumor Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Pediatric Brain Tumor Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Pediatric Brain Tumor Market Share (2019-2020)
Table 74. Central & South America Pediatric Brain Tumor Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Pediatric Brain Tumor Market Share by Type (2015-2020)
Table 76. Central & South America Pediatric Brain Tumor Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Pediatric Brain Tumor Market Share by Application (2015-2020)
Table 78. Abbott Company Details
Table 79. Abbott Business Overview
Table 80. Abbott Product
Table 81. Abbott Revenue in Pediatric Brain Tumor Business (2015-2020) (Million US$)
Table 82. Abbott Recent Development
Table 83. AbbVie Company Details
Table 84. AbbVie Business Overview
Table 85. AbbVie Product
Table 86. AbbVie Revenue in Pediatric Brain Tumor Business (2015-2020) (Million US$)
Table 87. AbbVie Recent Development
Table 88. Akorn Company Details
Table 89. Akorn Business Overview
Table 90. Akorn Product
Table 91. Akorn Revenue in Pediatric Brain Tumor Business (2015-2020) (Million US$)
Table 92. Akorn Recent Development
Table 93. Agios Company Details
Table 94. Agios Business Overview
Table 95. Agios Product
Table 96. Agios Revenue in Pediatric Brain Tumor Business (2015-2020) (Million US$)
Table 97. Agios Recent Development
Table 98. Baxter Company Details
Table 99. Baxter Business Overview
Table 100. Baxter Product
Table 101. Baxter Revenue in Pediatric Brain Tumor Business (2015-2020) (Million US$)
Table 102. Baxter Recent Development
Table 103. Bayer Company Details
Table 104. Bayer Business Overview
Table 105. Bayer Product
Table 106. Bayer Revenue in Pediatric Brain Tumor Business (2015-2020) (Million US$)
Table 107. Bayer Recent Development
Table 108. Epizyme Company Details
Table 109. Epizyme Business Overview
Table 110. Epizyme Product
Table 111. Epizyme Revenue in Pediatric Brain Tumor Business (2015-2020) (Million US$)
Table 112. Epizyme Recent Development
Table 113. Novartis Business Overview
Table 114. Novartis Product
Table 115. Novartis Company Details
Table 116. Novartis Revenue in Pediatric Brain Tumor Business (2015-2020) (Million US$)
Table 117. Novartis Recent Development
Table 118. Mylan Company Details
Table 119. Mylan Business Overview
Table 120. Mylan Product
Table 121. Mylan Revenue in Pediatric Brain Tumor Business (2015-2020) (Million US$)
Table 122. Mylan Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Brain Tumor Market Share by Type: 2020 VS 2026
Figure 2. Gliomas Features
Figure 3. Mixed Neuronal-Glial Tumors Features
Figure 4. Embryonal Tumors Features
Figure 5. Choroid Plexus Papilloma/Carcinoma Features
Figure 6. Tumors Arising From Non-Neuroepithelial Tissue Features
Figure 7. Meningeal Tumors Features
Figure 8. Global Pediatric Brain Tumor Market Share by Application: 2020 VS 2026
Figure 9. Hospitals And Clinics Case Studies
Figure 10. Medical Research Centers Case Studies
Figure 11. Academic Institutes Case Studies
Figure 12. Pediatric Brain Tumor Report Years Considered
Figure 13. Global Pediatric Brain Tumor Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Pediatric Brain Tumor Market Share by Regions: 2020 VS 2026
Figure 15. Global Pediatric Brain Tumor Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Pediatric Brain Tumor Market Share by Players in 2019
Figure 18. Global Top Pediatric Brain Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Brain Tumor as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Pediatric Brain Tumor Revenue in 2019
Figure 20. North America Pediatric Brain Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Pediatric Brain Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Pediatric Brain Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Pediatric Brain Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Pediatric Brain Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Pediatric Brain Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Pediatric Brain Tumor Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed